Epsilon Healthcare Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.265x

Epsilon Healthcare Ltd cash flow conversion efficiency. Based on the latest financial reports, Epsilon Healthcare Ltd (EPN) has a cash flow conversion efficiency ratio of 0.265x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$1.03 Million ≈ $728.19K USD) by net assets (AU$3.88 Million ≈ $2.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Epsilon Healthcare Ltd (2016–2025)

Cash flow conversion efficiency of Epsilon Healthcare Ltd from 2016 to 2025. This chart illustrates how Epsilon Healthcare Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Epsilon Healthcare Ltd for real-time trading data and today's change.

Epsilon Healthcare Ltd Cash Flow Conversion Ratio Explained

Epsilon Healthcare Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Epsilon Healthcare Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Epsilon Healthcare Ltd ranked by their cash flow conversion efficiency. Also see Epsilon Healthcare Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Ajooni Biotech Limited NSE:AJOONI	0.149x
PEPTONIC MEDICAL F:28L	-0.112x
Tambourah Metals Ltd AU:TMB	-0.007x
Merino & Co. Ltd AU:MNC	-0.297x
ConnectM Technology Solutions, Inc. NASDAQ:CNTM	0.098x
TOP Ships Inc. NYSE MKT:TOPS	0.081x
Form Bio Co. Ltd. KQ:377220	-0.066x
Cahaya Bintang Medan Tbk Pt JK:CBMF	0.000x

Annual Cash Flow Conversion Efficiency for Epsilon Healthcare Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Epsilon Healthcare Ltd from 2016 to 2025. Review EPN FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$1.91 Million ≈ $1.35 Million	AU$-3.13 Million ≈ $-2.21 Million	-1.635x	-413.48%
2024-12-31	AU$10.70 Million ≈ $7.57 Million	AU$-3.41 Million ≈ $-2.41 Million	-0.318x	-241.31%
2023-12-31	AU$7.54 Million ≈ $5.33 Million	AU$-703.37K ≈ $-497.68K	-0.093x	+66.36%
2022-12-31	AU$9.27 Million ≈ $6.56 Million	AU$-2.57 Million ≈ $-1.82 Million	-0.277x	+0.04%
2021-12-31	AU$19.57 Million ≈ $13.85 Million	AU$-5.43 Million ≈ $-3.84 Million	-0.277x	+19.21%
2020-12-31	AU$25.32 Million ≈ $17.91 Million	AU$-8.69 Million ≈ $-6.15 Million	-0.343x	+2.43%
2019-12-31	AU$22.32 Million ≈ $15.79 Million	AU$-7.86 Million ≈ $-5.56 Million	-0.352x	-68.97%
2018-12-31	AU$28.09 Million ≈ $19.87 Million	AU$-5.85 Million ≈ $-4.14 Million	-0.208x	-136.88%
2017-12-31	AU$21.36 Million ≈ $15.11 Million	AU$-1.88 Million ≈ $-1.33 Million	-0.088x	-574.77%
2016-12-31	AU$11.34 Million ≈ $8.03 Million	AU$-147.81K ≈ $-104.58K	-0.013x	--

About Epsilon Healthcare Ltd

AU:EPN Australia Drug Manufacturers - Specialty & Generic

Market Cap

$5.51 Million

AU$7.78 Million AUD

Market Cap Rank

#28291 Global

#1450 in Australia

Share Price

AU$0.02

Change (1 day)

-13.04%

52-Week Range

AU$0.02 - AU$0.04

All Time High

AU$1.08